Russell Richard E.

Avg. Two Year Performance

No purchase track record
35% Avg. Sale Return
16% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)6%44%34%35%
Sale Success Rate1 of 21 of 22 of 22 of 21 of 2

Minerva Neurosciences, Inc.

Drugs » Biotechnology

President:

Holdings: 33.77K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--